- Home
- SXC vs FTH Comparison
SXC vs FTH Comparison
Compare SXC & FTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SXC | FTH |
|---|---|---|
| Founded | 1960 | N/A |
| Country | United States | United States |
| Employees | 848 | 29 |
| Industry | Steel/Iron Ore | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 756.9M | 860.0M |
| IPO Year | 2011 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SXC | FTH |
|---|---|---|
| Price | $8.28 | $25.76 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 264.5K |
| Earning Date | 04-30-2026 | N/A |
| Dividend Yield | ★ 7.17% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.10 | N/A |
| Revenue | ★ $1,600,300,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $89.50 | ★ N/A |
| Revenue Growth | ★ 10.30 | N/A |
| 52 Week Low | $5.52 | $17.50 |
| 52 Week High | $9.74 | $37.90 |
Technical Indicators
Market Signals| Indicator | SXC | FTH |
|---|---|---|
| Relative Strength Index (RSI) | 43.80 | 48.87 |
| Support Level | $7.69 | $22.47 |
| Resistance Level | $8.38 | $31.61 |
| Average True Range (ATR) | 0.49 | 3.25 |
| MACD | -0.02 | -0.40 |
| Stochastic Oscillator | 35.87 | 28.14 |
Price Performance
Historical ComparisonAbout SXC SunCoke Energy Inc.
SunCoke Energy Inc operates as an independent producer of coke in the Americas. Its coke is mainly used as a principal raw material in the blast furnace steelmaking process as well as in the foundry production of casted iron. The company operates through two segments: Domestic Coke and Industrial Services. It offers metallurgical and thermal coal. The company also provides handling and/or mixing services to steel, coke, electric utility, coal-producing, and other manufacturing-based customers. The majority of revenue is derived from the Domestic Coke segment.
About FTH Faeth Therapeutics Inc. Common Stock
Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.